Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-09 Purchase |
2024-02-13 4:33 pm |
PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,557,593 | $10.64 | $27,212,790 | 10,689,545 (Indirect) |
View |
| 2023-12-11 Purchase(A) |
2024-01-17 7:06 pm |
Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,000,000 | $5 | $5,000,000 | 18,202,009 (Indirect) |
View |
| 2024-01-11 Purchase |
2024-01-12 5:01 pm |
Solid Biosciences Inc. | SLDB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. RA Capital Nexus Fund L.P. Director 10% Owner |
904,160 | $5.53 | $5,000,005 | 4,301,877 (Indirect) |
View |
| 2023-12-11 Purchase |
2023-12-13 4:33 pm |
Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,000,000 | $5 | $5,000,000 | 19,202,009 (Indirect) |
View |
| 2023-09-21 Purchase |
2023-09-25 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
2,700,000 | $3.0309 | $8,183,526 | 9,459,678 (Indirect) |
View |
| 2023-08-29 Purchase |
2023-08-31 5:26 pm |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
3,750,000 | $6.2 | $23,250,000 | 6,759,678 (Indirect) |
View |
| 2023-08-18 Purchase |
2023-08-22 5:01 pm |
AN2 Therapeutics Inc. | ANTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,777,778 | $9 | $16,000,002 | 5,551,295 (Indirect) |
View |
| 2023-07-21 Purchase |
2023-07-25 4:30 pm |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
5,161,290 | $7.75 | $39,999,998 | 14,932,063 (Indirect) |
View |
| 2023-07-19 Purchase |
2023-07-21 4:31 pm |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
495,008 | $12.46 | $6,167,800 | 9,668,878 (Indirect) |
View |
| 2023-07-05 Purchase |
2023-07-07 4:30 pm |
Black Diamond Therapeutics Inc. | BDTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director |
935,850 | $5 | $4,679,250 | 3,525,754 (Indirect) |
View |
| 2023-03-28 Purchase |
2023-03-30 5:03 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
509,145 | $29.07 | $14,798,693 | 7,856,612 (Indirect) |
View |
| 2023-03-24 Purchase |
2023-03-30 5:00 pm |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,461,538 | $16.25 | $39,999,993 | 11,416,948 (Indirect) |
View |
| 2023-03-23 Purchase |
2023-03-27 5:01 pm |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
498,556 | $26.99 | $13,457,372 | 7,347,467 (Indirect) |
View |
| 2023-02-14 Purchase |
2023-02-16 5:04 pm |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
1,250,000 | $16 | $20,000,000 | 1,311,247 (Indirect) |
View |
| 2023-01-20 Purchase |
2023-01-24 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,923,076 | $13 | $24,999,988 | 11,609,704 (Indirect) |
View |
| 2023-01-06 Purchase |
2023-01-10 5:14 pm |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,853,000 | $2.21 | $4,095,130 | 6,144,881 (Indirect) |
View |
| 2023-01-04 Purchase |
2023-01-06 4:39 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
180,703 | $7.2761 | $1,314,806 | 9,686,628 (Indirect) |
View |
| 2023-01-03 Purchase |
2023-01-05 4:43 pm |
IMARA Inc. | IMRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
629,297 | $3.9982 | $2,516,055 | 3,880,021 (Indirect) |
View |
| 2022-12-27 Purchase |
2022-12-29 5:00 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
4,089 | $5.9941 | $24,510 | 9,505,925 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-12 Option Award |
2024-02-14 7:49 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
549,755 | $13.5 | 5,400,739 (Indirect) |
View |
| 2024-02-12 Option Award |
2024-02-14 7:49 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
1,672,508 | $13.5 | 5,400,739 (Indirect) |
View |
| 2024-02-06 Option Award |
2024-02-08 5:16 pm |
N/A N/A |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,180,155 | $13.01 | 11,955,066 (Indirect) |
View |
| 2024-02-06 Option Award |
2024-02-08 5:16 pm |
N/A N/A |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,538,457 | $13.01 | 11,955,066 (Indirect) |
View |
| 2023-08-07 Option Award |
2023-08-09 8:00 pm |
N/A 2028-08-07 |
Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
45,000 | $0 | 45,000 (Indirect) |
View |
| 2023-08-09 Equity Swap |
2023-08-09 5:00 pm |
N/A N/A |
DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Former 10% owners and Director Director |
7,856,612 | $0 | 0 (Indirect) |
View |
| 2023-06-27 Option Award |
2023-06-28 9:00 pm |
N/A 2033-06-26 |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2023-06-21 Option Award |
2023-06-23 5:09 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
13,200 | $0 | 13,200 (Indirect) |
View |
| 2023-06-14 Option Award |
2023-06-16 5:15 pm |
N/A 2033-06-13 |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-13 4:21 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:30 pm |
N/A 2033-06-06 |
Nkarta Inc. | NKTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
22,500 | $0 | 22,500 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:00 pm |
N/A 2033-06-05 |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-08 5:15 pm |
N/A 2033-06-06 |
Solid Biosciences Inc. | SLDB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
9,650 | $0 | 9,650 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:47 pm |
N/A 2033-06-05 |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
17,000 | $0 | 17,000 (Indirect) |
View |
| 2023-06-06 Equity Swap |
2023-06-08 4:45 pm |
N/A N/A |
Satsuma Pharmaceuticals Inc. | STSA | Shah Rajeev M. Director 10% Owner |
5,914,252 | $0.91 | 0 (Indirect) |
View |
| 2023-05-26 Option Award |
2023-06-02 6:09 pm |
N/A 2033-05-25 |
Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
30,000 | $0 | 30,000 (Indirect) |
View |
| 2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
14,500 | $0 | 14,500 (Indirect) |
View |
| 2023-05-18 Option Award |
2023-05-22 5:22 pm |
N/A 2033-05-17 |
Eliem Therapeutics Inc. | ELYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
10,000 | $0 | 10,000 (Indirect) |
View |
| 2023-05-16 Option Award |
2023-05-17 9:10 pm |
N/A 2033-05-15 |
Black Diamond Therapeutics Inc. | BDTX | Shah Rajeev M. Director |
16,500 | $0 | 16,500 (Indirect) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:31 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Former 10% owner |
1,152,460 | $0 | 2,122,465 (Indirect) |
View |
| 2023-02-14 Conversion |
2023-02-16 5:04 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
1,928,476 | $0 | 1,311,247 (Indirect) |
View |
| 2023-02-09 Option Award |
2023-02-13 9:13 pm |
N/A 2023-02-09 |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
44,000 | $0 | 44,000 (Indirect) |
View |
Ownership |
2023-02-09 8:06 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 1,928,476 (Indirect) |
View |